Yi-Ling Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yi-Ling Lin has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Mengtao Li
Division of Diagnostic and Surgical Sciences, School of Dentistry, University of California, Los Angeles, USA
6 shared publicationsJohn R. Basile
Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, USA
5 shared publicationsSanjay Mallya
Division of Diagnostic and Surgical Sciences, School of Dentistry, University of California, Los Angeles, USA
2 shared publicationsSsu-Yi Lu
Section of Oral Pathology, Department of Diagnostic and Surgical Sciences, School of Dentistry, University of California, Los Angeles, CA 90095, USA
2 shared publicationsCraig C. Thiede
Private Practice and Children′s Hospital of Orange County Orange California USA
1 shared publication- Daniel J. Weisenberger
Department of Cancer Biology, Keck School of Medicine, University of Southern California
1 shared publication
Latest Publications
- Open Access
- 21 April 2026
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 157 (10) , 1092-1104
Oral virome in health and disease
- 21 April 2026
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 157 (10) , 1092-1104
Open AccessOral virome in health and disease
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Dentistry
- Vol. 2026 (1) , 8903042
Cementoblastoma With Bony and Soft Tissue Recurrences Following a Primary Molar Lesion: A Case Report
Cementoblastoma is a rare benign odontogenic neoplasm defined by its fusion to the root of a tooth and characterized by radiating cementoid deposition with peripheral active cementoblasts. Although recurrence is uncommon following complete excision, when it occurs, it typically arises at the original site. We report an unusual recurrent cementoblastoma associated with a primary mandibular molar in a pediatric patient. Review of records from the initial presentation documented a radiopaque mandibular lesion fused to the roots of the lower right primary first molar with cortical expansion, which was treated by extraction of the involved tooth and removal of the associated lesion. Eighteen months later, the patient presented with recurrence as multiple discrete, noncoalescent masses involving the alveolar crest, lingual cortical bone, and buccal gingival soft tissue. All recurrent lesions, including the soft tissue lesion, showed histologic features consistent with developing cementoblastoma. Each lesion demonstrated a radial growth pattern forming a well‐circumscribed spherical mass. This case documents recurrence after apparently conservative initial removal of a cementoblastoma arising in the primary dentition, and supports the concept that neither persistent root attachment nor an osseous environment is required for lesion development or for maintaining the characteristic radial growth pattern. The findings highlight the importance of complete excision at initial presentation to reduce the risk of recurrence.
- 1 January 2026
- Published by Wiley in Case Reports in Dentistry
- Vol. 2026 (1) , 8903042
Open AccessCementoblastoma With Bony and Soft Tissue Recurrences Following a Primary Molar Lesion: A Case Report
Cementoblastoma is a rare benign odontogenic neoplasm defined by its fusion to the root of a tooth and characterized by radiating cementoid deposition with peripheral active cementoblasts. Although recurrence is uncommon following complete excision, when it occurs, it typically arises at the original site. We report an unusual recurrent cementoblastoma associated with a primary mandibular molar in a pediatric patient. Review of records from the initial presentation documented a radiopaque mandibular lesion fused to the roots of the lower right primary first molar with cortical expansion, which was treated by extraction of the involved tooth and removal of the associated lesion. Eighteen months later, the patient presented with recurrence as multiple discrete, noncoalescent masses involving the alveolar crest, lingual cortical bone, and buccal gingival soft tissue. All recurrent lesions, including the soft tissue lesion, showed histologic features consistent with developing cementoblastoma. Each lesion demonstrated a radial growth pattern forming a well‐circumscribed spherical mass. This case documents recurrence after apparently conservative initial removal of a cementoblastoma arising in the primary dentition, and supports the concept that neither persistent root attachment nor an osseous environment is required for lesion development or for maintaining the characteristic radial growth pattern. The findings highlight the importance of complete excision at initial presentation to reduce the risk of recurrence.
- Open Access
- 1 June 2023
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-13
The impact and outcomes of cancer-macrophage fusion
Background: Cancer’s hallmark feature is its ability to evolve, leading to metastasis and recurrence. Although genetic mutations and epigenetic changes have been implicated, they don’t fully explain the leukocytic traits that many cancers develop. Cell fusion between cancer and somatic cells, particularly macrophages, has been suggested as an alternative pathway for cancer cells to obtain new traits by acquiring exogenous genetic material. Methods: This study aims to investigate the potential biological outcomes of tumor-myeloid cell fusion by generating tumor-macrophage hybrid cells. Two clones with markedly different tumorigenicity were selected, and RNA-seq was used to compare their RNA expressions with that of the control cells. Based on the results that the hybrid cells showed differential activation in several upstream regulator pathways that impact their biological behaviors, the hybrid cells’ abilities to recruit stromal cells and establish angiogenesis as well as their cell cycle distributions were investigated through in vitro and in vivo studies. Results: Although both hybrid clones demonstrated p53 activation and reduced growth rates, they exhibited distinct cell cycle distributions and ability to grow in vivo. Notably, while one clone was highly tumorigenic, the other showed little tumorigenicity. Despite these differences, both hybrid clones were potent environmental modifiers, exhibiting significant abilities to recruit stromal and immune cells and establish angiogenesis. Conclusions: The study revealed that tumor-somatic cell fusion is a potent environmental modifier that can modulate tumor survival and evolution, despite its relatively low occurrence. These findings suggest that tumor-somatic cell fusion could be a promising target for developing new cancer therapies. Furthermore, this study provides an experimental animal platform to investigate cancer-myeloid fusion and highlights the potential role of tumor-somatic cell fusion in modulating the tumor environment.
- 1 June 2023
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-13
Open AccessThe impact and outcomes of cancer-macrophage fusion
Background: Cancer’s hallmark feature is its ability to evolve, leading to metastasis and recurrence. Although genetic mutations and epigenetic changes have been implicated, they don’t fully explain the leukocytic traits that many cancers develop. Cell fusion between cancer and somatic cells, particularly macrophages, has been suggested as an alternative pathway for cancer cells to obtain new traits by acquiring exogenous genetic material. Methods: This study aims to investigate the potential biological outcomes of tumor-myeloid cell fusion by generating tumor-macrophage hybrid cells. Two clones with markedly different tumorigenicity were selected, and RNA-seq was used to compare their RNA expressions with that of the control cells. Based on the results that the hybrid cells showed differential activation in several upstream regulator pathways that impact their biological behaviors, the hybrid cells’ abilities to recruit stromal cells and establish angiogenesis as well as their cell cycle distributions were investigated through in vitro and in vivo studies. Results: Although both hybrid clones demonstrated p53 activation and reduced growth rates, they exhibited distinct cell cycle distributions and ability to grow in vivo. Notably, while one clone was highly tumorigenic, the other showed little tumorigenicity. Despite these differences, both hybrid clones were potent environmental modifiers, exhibiting significant abilities to recruit stromal and immune cells and establish angiogenesis. Conclusions: The study revealed that tumor-somatic cell fusion is a potent environmental modifier that can modulate tumor survival and evolution, despite its relatively low occurrence. These findings suggest that tumor-somatic cell fusion could be a promising target for developing new cancer therapies. Furthermore, this study provides an experimental animal platform to investigate cancer-myeloid fusion and highlights the potential role of tumor-somatic cell fusion in modulating the tumor environment.
- Open Access
- 19 September 2022
- Published by Springer Nature in Research Square
Cancer cell-macrophage fusion increases tumor cell heterogeneity and reshapes their microenvironment
The trademark of cancer is the ability to evolve, which lays the grounds for progressive events such as metastasis and recurrence. Although genetic mutations and epigenetic changes have been implicated as the mechanisms, they don’t explain why many cancers develop leukocytic traits. Cell fusion between cancer and somatic cells, particularly macrophages, has been suggested as an alternative pathway for cancer cells to obtain new traits via acquiring exogenous genetic material. In this study, tumor-macrophage hybrid cells were generated, and two clones, both grew slowly yet with very different tumorigenicity, were selected for further study. Despite their very different abilities to form tumors in mice, both clones showed significant abilities to influence the tumor microenvironment. RNA-seq of the hybrid cell clones revealed the differential expression profiles of the hybrid cells that contributed to the biological behaviors. This study emphasizes the role of hybrid cells as potent environmental modifiers that aid tumor survival and evolution despite their minority status among the tumor cells. This study also provides an animal experimental platform to study cancer-myeloid fusion and a potential direction for novel therapeutic interventions.
- 19 September 2022
- Published by Springer Nature in Research Square
Open AccessCancer cell-macrophage fusion increases tumor cell heterogeneity and reshapes their microenvironment
The trademark of cancer is the ability to evolve, which lays the grounds for progressive events such as metastasis and recurrence. Although genetic mutations and epigenetic changes have been implicated as the mechanisms, they don’t explain why many cancers develop leukocytic traits. Cell fusion between cancer and somatic cells, particularly macrophages, has been suggested as an alternative pathway for cancer cells to obtain new traits via acquiring exogenous genetic material. In this study, tumor-macrophage hybrid cells were generated, and two clones, both grew slowly yet with very different tumorigenicity, were selected for further study. Despite their very different abilities to form tumors in mice, both clones showed significant abilities to influence the tumor microenvironment. RNA-seq of the hybrid cell clones revealed the differential expression profiles of the hybrid cells that contributed to the biological behaviors. This study emphasizes the role of hybrid cells as potent environmental modifiers that aid tumor survival and evolution despite their minority status among the tumor cells. This study also provides an animal experimental platform to study cancer-myeloid fusion and a potential direction for novel therapeutic interventions.
- Open Access
- 28 June 2021
- Published by Elsevier in The American Journal of Pathology
- Vol. 191 (10) , 1822-1836
Exposure to Microbial Metabolite Butyrate Prolongs the Survival Time and Changes the Growth Pattern of Human Papillomavirus 16 E6/E7-Immortalized Keratinocytes in Vivo
- 28 June 2021
- Published by Elsevier in The American Journal of Pathology
- Vol. 191 (10) , 1822-1836
Open AccessExposure to Microbial Metabolite Butyrate Prolongs the Survival Time and Changes the Growth Pattern of Human Papillomavirus 16 E6/E7-Immortalized Keratinocytes in Vivo
- 18 December 2018
- Published by Wiley in Oral Diseases
- Vol. 25 (3) , 796-802
Computer‐assisted analysis of immunohistological parameters in oral giant cell granulomas
Objective: The aim of this study was to examine the relationship between active osteoclasts, as defined by positive nuclear NFATc1 signals, and the clinical behaviors of oral giant cell granulomas.Materials And Methods: NFATc1 immunohistochemical and TRAP‐Cbfa1 double immunofluorescence stainings were performed on 9 cases of peripheral giant cell granulomas (PGCGs), 9 cases of central giant cell granulomas (CGCGs) with a recurrent history, and 10 cases of CGCGs without a recurrent history. The results were photographed and quantified by ImageJ. Nine osteoclast‐ and osteoblast‐related parameters were analyzed with conventional statistics and with Rapidminer, an open data analysis platform for computer predictive modeling.Results: Peripheral giant cell granulomas had a significantly lower percentage of active osteoclasts than CGCGs. The recurrent CGCG subgroup had the highest active osteoclast density in comparison with non‐recurrent CGCG subgroup and PCCGs.Conclusions: The study strongly indicates that the status of osteoclasts, as defined by the subcellular NFATc1 signal, has an association with the clinical behavior of oral giant cell granulomas. NFATc1 staining may be useful as a biomarker to predict recurrence of CGCGs. The study also illustrates the potential application of data science tools in studying pathology to facilitate the discovery of disease‐associated biomarkers.
- 18 December 2018
- Published by Wiley in Oral Diseases
- Vol. 25 (3) , 796-802
Computer‐assisted analysis of immunohistological parameters in oral giant cell granulomas
Objective: The aim of this study was to examine the relationship between active osteoclasts, as defined by positive nuclear NFATc1 signals, and the clinical behaviors of oral giant cell granulomas.Materials And Methods: NFATc1 immunohistochemical and TRAP‐Cbfa1 double immunofluorescence stainings were performed on 9 cases of peripheral giant cell granulomas (PGCGs), 9 cases of central giant cell granulomas (CGCGs) with a recurrent history, and 10 cases of CGCGs without a recurrent history. The results were photographed and quantified by ImageJ. Nine osteoclast‐ and osteoblast‐related parameters were analyzed with conventional statistics and with Rapidminer, an open data analysis platform for computer predictive modeling.Results: Peripheral giant cell granulomas had a significantly lower percentage of active osteoclasts than CGCGs. The recurrent CGCG subgroup had the highest active osteoclast density in comparison with non‐recurrent CGCG subgroup and PCCGs.Conclusions: The study strongly indicates that the status of osteoclasts, as defined by the subcellular NFATc1 signal, has an association with the clinical behavior of oral giant cell granulomas. NFATc1 staining may be useful as a biomarker to predict recurrence of CGCGs. The study also illustrates the potential application of data science tools in studying pathology to facilitate the discovery of disease‐associated biomarkers.
- Open Access
- 1 June 2018
- Published by Elsevier in Bone Reports
- Vol. 8, 104-109
Bisphosphonate-related osteonecrosis of the jaw: a mechanobiology perspective
- 1 June 2018
- Published by Elsevier in Bone Reports
- Vol. 8, 104-109
Open AccessBisphosphonate-related osteonecrosis of the jaw: a mechanobiology perspective
- 1 October 2014
- Published by Elsevier in Experimental Cell Research
- Vol. 328 (1) , 32-43
Mitf regulates osteoclastogenesis by modulating NFATc1 activity
- 1 October 2014
- Published by Elsevier in Experimental Cell Research
- Vol. 328 (1) , 32-43
Mitf regulates osteoclastogenesis by modulating NFATc1 activity
- Open Access
- 6 July 2010
- Published by Springer Nature in Head and Neck Pathology
- Vol. 4 (3) , 253-256
A Case of Odontogenic Myxoma with Unusual Histological Features Mimicking a Fibro-Osseous Process
Odontogenic myxoma is a rare benign but locally aggressive odontogenic tumor. This report describes a case of odontogenic myxoma producing diffusely dispersed calcified products in a pattern reminiscent of a fibro-osseous lesion of the jaw. Differential diagnoses for myxoid lesions of the jaws also are discussed. This paper highlights how an odontogenic myxoma can produce a large amount of calcified products to mimic a fibro-osseous process.
- 6 July 2010
- Published by Springer Nature in Head and Neck Pathology
- Vol. 4 (3) , 253-256
Open AccessA Case of Odontogenic Myxoma with Unusual Histological Features Mimicking a Fibro-Osseous Process
Odontogenic myxoma is a rare benign but locally aggressive odontogenic tumor. This report describes a case of odontogenic myxoma producing diffusely dispersed calcified products in a pattern reminiscent of a fibro-osseous lesion of the jaw. Differential diagnoses for myxoid lesions of the jaws also are discussed. This paper highlights how an odontogenic myxoma can produce a large amount of calcified products to mimic a fibro-osseous process.